The efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating advanced urothelial cancer: a meta-analysis of clinical trials

Survival outcomes in advanced urothelial cancer (UC) are dismal. Over the past years, immunotherapy remains an evolving treatment modality for these patients. This meta-analysis was performed to comprehensively evaluate the efficacy and safety of immune checkpoint inhibitors. For this purpose, 18 cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fei, Wang, Yu, Xie, Kunfeng, Fang, Yunze, Du, Yuejun, Hou, Lina, Tan, Wanlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436906/
https://www.ncbi.nlm.nih.gov/pubmed/34424218
http://dx.doi.org/10.18632/aging.203429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436906/
https://www.ncbi.nlm.nih.gov/pubmed/34424218
http://dx.doi.org/10.18632/aging.203429

Ejemplares similares